---
title: "Kits Eyecare Expands Pangolin Smart Glasses Lineup and Launches New App"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/274269527.md"
datetime: "2026-01-30T08:00:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274269527.md)
  - [en](https://longbridge.com/en/news/274269527.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274269527.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/274269527.md) | [繁體中文](https://longbridge.com/zh-HK/news/274269527.md)


# Kits Eyecare Expands Pangolin Smart Glasses Lineup and Launches New App

Kits Eyecare Ltd. has announced a major expansion of its Pangolin Smart Glasses franchise in 2026, introducing three new Pangolin 3 designs, including sport and cycling models, and unveiling the upcoming Pangolin 4 platform with expanded functionality. The new smart glasses are designed to operate on an all-new KITS app, soon to launch on the App Store and Google Play. Leveraging its vertically integrated onshore lens lab, KITS will continue to offer prescription lenses paired with smart glasses, delivering orders anywhere in North America in as little as one day. This expansion aims to streamline the customer experience and reinforce KITS’s position as a leader in innovative eyewear technology. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kits Eyecare Ltd. published the original content used to generate this news brief via CNW (Ref. ID: C2689) on January 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### 相关股票

- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-CN/quote/IBB.US.md)
- [Ocular Therap (OCUL.US)](https://longbridge.com/zh-CN/quote/OCUL.US.md)
- [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-CN/quote/SBIO.US.md)
- [Health Care Select Sector SPDR (XLV.US)](https://longbridge.com/zh-CN/quote/XLV.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-CN/quote/PBE.US.md)
- [Ark Genomic Revolution ETF (ARKG.US)](https://longbridge.com/zh-CN/quote/ARKG.US.md)
- [iShares US Medical Devices (IHI.US)](https://longbridge.com/zh-CN/quote/IHI.US.md)
- [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-CN/quote/BIB.US.md)
- [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-CN/quote/XBI.US.md)
- [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-CN/quote/FBT.US.md)
- [SPDR S&P Health Equip (XHE.US)](https://longbridge.com/zh-CN/quote/XHE.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-CN/quote/BBH.US.md)
- [Direxion S&P Biotech Bear 3X (LABD.US)](https://longbridge.com/zh-CN/quote/LABD.US.md)

## 相关资讯与研究

- [Perimeter Posts Record 2025 Revenue and Wins FDA Approval for AI Breast Imaging Device](https://longbridge.com/zh-CN/news/281274047.md)
- [BUZZ-Tempus AI rises after study shows AI-driven alerts improve heart valve treatment](https://longbridge.com/zh-CN/news/281390073.md)
- [Vertex Pharmaceuticals Says US FDA Approves Label Expansion for Alyftrek, Trikafta](https://longbridge.com/zh-CN/news/281365753.md)
- [Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update](https://longbridge.com/zh-CN/news/281525623.md)
- [Zevenbergen Capital Investments LLC Invests $32.14 Million in Insulet Corporation $PODD](https://longbridge.com/zh-CN/news/281179756.md)